4-BROMO-1H-PYRAZOLE-5-CARBOXALDEHYDE DIMER 95+%
|
- $66 - $75
- Product name: 4-BROMO-1H-PYRAZOLE-5-CARBOXALDEHYDE DIMER 95+%
- CAS: 1212466-82-4
- MF: C8H6Br2N4O2
- MW: 349.97
- EINECS:
- MDL Number:MFCD08445454
- Synonyms:4-BROMO-1H-PYRAZOLE-5-CARBOXALDEHYDE DIMER 95+%;3,8-Dibromo-4H,9H-dipyrazolo[1,5-a:1',5'-d]pyrazine-4,9-diol, 3,8-Dibromo-4,9-dihydroxy-4H,9H-dipyrazolo[1,5-a:1',5'-d]pyrazine;4H,9H-Dipyrazolo[1,5-a:1',5'-d]pyrazine-4,9-diol, 3,8-dibromo-, (4R)-
3 prices
Selected condition：
Brand
- Apolloscientific
- SynQuest Laboratories
- TRC
Package
- 50mg
- 500mg
- ManufacturerApolloscientific
- Product numberOR017542
- Product description4-Bromo-1H-pyrazole-5-carboxaldehydedimer 95+%
- Packaging500mg
- Price$66
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number4H04-9-X0
- Product description4-Bromo-1H-pyrazole-5-carboxaldehyde dimer 95.0%
- Packaging500mg
- Price$72
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB998088
- Product description4-Bromo-1H-pyrazole-5-carboxaldehydeDimer
- Packaging50mg
- Price$75
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Apolloscientific | OR017542 | 4-Bromo-1H-pyrazole-5-carboxaldehydedimer 95+% | 500mg | $66 | 2021-12-16 | Buy |
| SynQuest Laboratories | 4H04-9-X0 | 4-Bromo-1H-pyrazole-5-carboxaldehyde dimer 95.0% | 500mg | $72 | 2021-12-16 | Buy |
| TRC | B998088 | 4-Bromo-1H-pyrazole-5-carboxaldehydeDimer | 50mg | $75 | 2021-12-16 | Buy |
Properties
Melting point :178-180°C
Boiling point :592.7±50.0 °C(Predicted)
Density :2.76±0.1 g/cm3(Predicted)
pka :10.69±0.40(Predicted)
Boiling point :592.7±50.0 °C(Predicted)
Density :2.76±0.1 g/cm3(Predicted)
pka :10.69±0.40(Predicted)
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||
| Precautionary statements: |
|